Abstract
A LCMS method was developed and validated for the determination of buprenorphine (BUP), norbuprenorphine (NBUP), buprenorphine glucuronide (BUP-Gluc), and norbuprenorphine glucuronide (NBUP-Gluc) in placenta. Quantification was achieved by selected ion monitoring of m/z 468.4 (BUP), 414.3 (NBUP), 644.4 (BUP-Gluc), and 590 (NBUP-Gluc). BUP and NBUP were identified monitoring MS2 fragments m/z 396, 414 and 426 for BUP, and 340, 364 and 382 for NBUP, and glucuronide conjugates monitoring MS3 fragments m/z 396 and 414 for BUP-Gluc, and 340 and 382 for NBUP-Gluc. Linearity was 1–50 ng/g. Intra-day, inter-day and total assay imprecision (% RSD) were <13.4%, and analytical recoveries were 96.2–113.1%. Extraction efficiencies ranged from 40.7–68%, process efficiencies 38.8–70.5%, and matrix effect 1.3–15.4%. Limits of detection were 0.8 ng/g for all compounds. An authentic placenta from an opioid-dependent pregnant woman receiving BUP pharmacotherapy was analyzed. BUP was not detected but metabolite concentrations were NBUP-Gluc 46.6, NBUP 15.7 and BUP-Gluc 3.2 ng/g.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-009-2706-z/MediaObjects/216_2009_2706_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-009-2706-z/MediaObjects/216_2009_2706_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00216-009-2706-z/MediaObjects/216_2009_2706_Fig3_HTML.gif)
Similar content being viewed by others
References
Drug Addiction Treatment Act of 2000 (2000) p. 111 STAT. 1101
Lejeune C, Simmat-Durand L, Gourarier L et al (2006) Drug Alcohol Depend 82:250–257
Fischer G, Johnson RE, Eder H et al (2000) Addiction 95(2):239–244
Dunlop AJ, Panjari M, O’Sullivan H et al (2003) Clinical guidelines for the use of buprenorphine in pregnancy. Turning Point Alcohol and Drug Centre, Fitzroy
Jones HE, Johnson RE, Jasinski DR et al (2005) Drug Alcohol Depend 79:1–10
Kobayashi K, Tamamoto T, Chiba K et al (1998) Drug Metab Dispos 26:818–821
Bottcher M, Beck O (2005) J Anal Toxicol 29:769–76
Blom Y, Bondesson U (1985) J Chromatogr 338:89–98
George S, George C, Chauhan M (2004) Forensic Sci Int 143:121–125
Lange WR, Fudala PJ, Dax EM et al (1990) Drug Alcohol Depend 26:19–28
Lisi AM, Kazlauskas R, Trout GJ (1997) J Chromatogr B Biomed Sci Appl 692:67–77
Cone EJ, Gorodetzky CW, Yousefnejad D et al (1985) J Chromatogr 337:291–300
Vincent F, Bessard J, Vacheron J et al (1999) J Anal Toxicol 23:270–279
Ohtani M, Shibuya F, Kotaki H et al (1989) J Chromatogr 487:469–475
Kuhlman JJ, Magluilo J, Cone E et al (1996) J Anal Toxicol 20:229–235
Everhart ET, Cheung P, Shwonek P et al (1997) Clin Chem 43:2292–2302
Moody DE, Laycock JD, Spanbauer AC et al (1997) J Anal Toxicol 21:406–411
Tiong GKL, Olley JE (1988) Naunyn-Schmiedeberg's Arch Pharmacol 338:202–206
Gunnar T, Ariniemi K, Lillsunde P (2005) J Mass Spectrom 40:739–753
De Giovanni N, Fucci N, Scarlata S et al (2005) Clinical Chemistry and Laboratory Medicine. 43:1377–1379
Vinner E, Vignau J, Thibault D et al (2003) Forensic Science International 133:57–62
Hegstad S, Khiabani HZ, Oiestad EL et al (2007) J Anal Toxicol 31:214–219
Kronstrand R, Selden TG, Josefsson M (2003) J Anal Toxicol 27:464–70
Cirimele V, Etienne S, Villain M et al (2004) Forensic Sci Int 143:153–156
Cirimele V, Kintz P, Lohner S et al (2003) J Anal Toxicol 27:103–105
Huang W, Moody DE, McCance-Katz EF (2006) Ther Drug Monit 28:245–251
Tracqui A, Kintz P, Mangin P (1997) Journal of Forensic Sciences 42(1):111–114
Miller EI, Torrance HJ, Oliver JS (2006) J Anal Toxicol 30:115–119
Favretto D, Frison G, Vogliardi S et al (2006) Rapid Communications in Mass Spectrometry. 20:1257–1265
Liu AC, Lin TY, Su LW et al (2008) Talanta 75:198–204
Hull MJ, Bierer MF, Griggs DA et al (2008) J Anal Toxicol 32:516–521
Kacinko S, Concheiro-Guisan M, Shakleya D et al (2008) Anal Bioanal Chem 392:903–911
Rodriguez-Rosas ME, Lofwall MR, Strain EC et al (2007) Journal of Chromatography B. Analytical Technologies in the Biomedical and Life Sciences 850:538–543
Musshoff F, Trafkowski J, Kuepper U et al (2006) J Mass Spectrom 41:633–640
Ceccato A, Klinkenberg R, Hubert P et al (2003) J Pharm Biomed Anal 32:619–631
Polettini A, Huestis MA (2001) J Chromatogr B Biomed Sci Appl 754:447–459
Murphy CM, Huestis MA (2005) J Mass Spectrom 40:70–74
Scislowski M, Piekoszewski W, Kamenczak A et al (2005) J Anal Toxicol 29:249–253
Hoja H, Marquet P, Verneuil B et al (1997) J Anal Toxicol 21:160–165
Wilkins DG, Rollins DE, Valdez AS et al (1999) J Anal Toxicol 23:409–415
Kintz P (1993) J Anal Toxicol 17:443–444
Goodwin RS, Wilkins DG, Averin O et al (2007) Clin Chem 53:2136–2143
Thieme D, Sachs H, Thevis M (2008) J Mass Spectrom 43:974–979
Kintz P, Tracqui A, Mangin P et al (1996) J Anal Toxicol 20:393–397
Kacinko SL, Shakleya DM, Huestis MA (2008) Analytical Chemistry 80:246–252
Grimm D, Pauly E, Poschl J et al (2005) Ther Drug Monit 27:526–530
Krouwer JS, Rabinowitz R (1984) Clin Chem 30:290–292
European Union Decision 2002/657/EC (17/8/2002) (2002) Off J Eur Commun 221:8–36
Acknowledgments
This research was supported by the National Institutes of Health, Intramural Research Program, National Institute on Drug Abuse, and funding for Marta Concheiro, Ph.D. from the Ministerio de Educación y Ciencia of Spain (Grant number EX-2007-1194). The authors would like to thank Drs. Fred Askin, Gerrun March, and Leigh Ruane from Johns Hopkins Bayview Medical Center (Baltimore, MD) for their help in providing placenta samples.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Concheiro-Guisan, M., Shakleya, D.M. & Huestis, M.A. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry. Anal Bioanal Chem 394, 513–522 (2009). https://doi.org/10.1007/s00216-009-2706-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-009-2706-z